Eventide Asset Management - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 241 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$13,947,600
+0.6%
1,970,0000.0%0.25%
+7.3%
Q2 2023$13,868,800
+50.8%
1,970,000
+78.6%
0.23%
+38.5%
Q1 2023$9,198,094
+8.9%
1,102,889
+5.3%
0.17%
-54.8%
Q4 2018$8,449,000
+5.8%
1,047,0000.0%0.37%
+27.6%
Q3 2018$7,989,000
+461.0%
1,047,000
+261.0%
0.29%
+295.9%
Q4 2017$1,424,000
-6.3%
290,0000.0%0.07%
-14.0%
Q3 2017$1,520,000
-5.7%
290,0000.0%0.09%
-14.0%
Q2 2017$1,612,000290,0000.10%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
RP Management, LLC 3,846,154$27,230,77026.28%
Prosight Management, LP 2,408,135$17,049,5965.40%
Kynam Capital Management, LP 3,133,193$22,183,0063.63%
Saturn V Capital Management LP 982,458$6,955,8032.91%
AlphaCentric Advisors LLC 649,000$4,594,9202.61%
TANG CAPITAL MANAGEMENT LLC 1,800,000$12,744,0001.80%
SILVERARC CAPITAL MANAGEMENT, LLC 791,671$5,605,0311.70%
Eversept Partners, LP 2,479,103$17,552,0491.48%
DAFNA Capital Management LLC 652,000$4,616,1601.44%
Avoro Capital Advisors LLC 11,550,000$81,774,0001.28%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders